Treatment of Hemorrhagic Fever With Ribavirin
Condition(s):Hemorrhagic FeverLast Updated:July 22, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Hemorrhagic FeverLast Updated:July 22, 2022Not yet recruiting
Condition(s):CCHFLast Updated:October 5, 2023Recruiting
Condition(s):Viral Hemorrhagic FeverLast Updated:April 5, 2022Recruiting
Condition(s):Hepatitis C; CirrhosisLast Updated:July 21, 2022Not yet recruiting
Condition(s):Lassa FeverLast Updated:January 25, 2024Not yet recruiting
Condition(s):Chronic Hepatitis C; Medication ReactionLast Updated:March 13, 2024Recruiting
Condition(s):Lassa FeverLast Updated:January 18, 2024Not yet recruiting
Condition(s):Acute Respiratory Tract Infections; Pneumonia; Respiratory Syncytial Virus (RSV)Last Updated:July 6, 2023Recruiting
Condition(s):Hemodialysis Access FailureLast Updated:September 13, 2023Recruiting
Condition(s):Lassa Fever; Lassa Virus Infection; Pregnancy Complications; Acute Kidney Injury; Acute Kidney Failure; ComaLast Updated:July 19, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.